TAISEI CORP. ADR/ 1/4 (F:TKK) — Stock Price

€20.40 EUR
▲ 0.00% today

TAISEI CORP. ADR/ 1/4 (F:TKK) is currently trading at €20.40 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €10.40 and €26.80. This page tracks TAISEI CORP. ADR/ 1/4's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see TKK market cap.

TAISEI CORP. ADR/ 1/4 (TKK) Stock Price Chart — Daily History & Trading Volume

The chart below tracks TAISEI CORP. ADR/ 1/4's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

TAISEI CORP. ADR/ 1/4 Income Statement — Revenue, Profit & Earnings by Year

TAISEI CORP. ADR/ 1/4's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 2025202420232022
Total Revenue €2.15 Trillion €1.77 Trillion €1.64 Trillion €1.54 Trillion
Cost of Revenue €1.92 Trillion €1.64 Trillion €1.49 Trillion €1.36 Trillion
Gross Profit €231.14 Billion €127.40 Billion €147.77 Billion €187.74 Billion
Research & Development
SG&A €110.98 Billion €100.92 Billion €93.03 Billion €91.66 Billion
Total Operating Expenses €2.03 Trillion €1.74 Trillion €1.59 Trillion €1.45 Trillion
Operating Income €120.16 Billion €26.48 Billion €54.74 Billion €96.08 Billion
EBITDA
EBIT
Interest Expense €3.42 Billion €1.23 Billion €861.00 Million €910.00 Million
Income Before Tax €178.25 Billion €57.09 Billion €68.09 Billion €103.50 Billion
Income Tax Expense
Net Income €123.82 Billion €40.27 Billion €47.12 Billion €71.44 Billion

TAISEI CORP. ADR/ 1/4 Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes TAISEI CORP. ADR/ 1/4's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 2025202420232022
Total Assets €2.43 Trillion €2.58 Trillion €2.02 Trillion €1.96 Trillion
Total Current Assets €1.60 Trillion €1.63 Trillion €1.35 Trillion €1.30 Trillion
Cash & Equivalents
Short-term Investments €60.00 Billion
Net Receivables €939.16 Billion €864.69 Billion €688.77 Billion €575.60 Billion
Inventory €264.68 Billion €253.04 Billion €203.10 Billion €168.66 Billion
Property, Plant & Equipment
Goodwill
Total Liabilities €1.53 Trillion €1.62 Trillion €1.18 Trillion €1.08 Trillion
Total Current Liabilities €1.29 Trillion €1.30 Trillion €1.02 Trillion €926.36 Billion
Long-term Debt €190.10 Billion €265.47 Billion €119.72 Billion €106.41 Billion
Net Debt €74.83 Billion
Total Stockholder Equity €866.19 Billion €929.33 Billion €829.19 Billion €868.89 Billion
Retained Earnings €649.20 Billion €558.72 Billion €562.77 Billion €591.38 Billion

TAISEI CORP. ADR/ 1/4 Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how TAISEI CORP. ADR/ 1/4 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 2025202420232022
Operating Cash Flow €-13.84 Billion €40.61 Billion €30.10 Billion €80.51 Billion
Capital Expenditures €31.94 Billion €122.31 Billion €16.16 Billion €13.23 Billion
Free Cash Flow €-45.78 Billion €-81.70 Billion €13.94 Billion €67.28 Billion
Investing Cash Flow
Financing Cash Flow
Dividends Paid €23.88 Billion €24.38 Billion €25.72 Billion €26.60 Billion
Stock-Based Compensation
Depreciation €16.39 Billion €13.11 Billion €11.48 Billion €10.91 Billion
Change in Cash €-134.79 Billion €14.89 Billion €-80.90 Billion €2.48 Billion

TAISEI CORP. ADR/ 1/4 Earnings History — EPS Actual vs. Analyst Estimates

Track TAISEI CORP. ADR/ 1/4's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 11, 2026
Feb 04, 2026
Nov 04, 2025
Aug 07, 2025
May 13, 2025
Feb 06, 2025
Nov 07, 2024